With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19 Medical Dialogues Bureau28 March 2020 6:39 AM GMTAbbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID...
Abbott gets USFDA emergency use authorization for COVID-19 molecular test Medical Dialogues Bureau20 March 2020 4:45 AM GMTThe Abbott m2000 RealTime System is a molecular solution featuring a broad menu of tests, including ones for infectious diseases.
Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system Medical Dialogues Bureau1 Feb 2020 7:30 AM GMTNew Delhi: Abbott today announced that its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use i...
Drug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; Details Farhat Nasim14 Jan 2020 9:02 AM GMTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) recently flagged 49...
Abbott gets USFDA nod for less-invasive surgical approach for heart pump Medical Dialogues Bureau9 Jan 2020 10:02 AM GMTNew Delhi: Abbott recently announced U.S. Food and Drug Administration (USFDA) approval of a new alternative surgical technique for Abbott's HeartMate ...
NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details Medical Dialogues Bureau15 Nov 2019 10:59 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 5:53 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Abbott discovers new strain of HIV, keeping global health community step ahead of virus Medical Dialogues Bureau10 Nov 2019 3:30 AM GMTNew Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Gro...
Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system Medical Dialogues Bureau5 Nov 2019 7:35 AM GMTThe U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of a...
Abbott, Australian Blood Service ink agreement for Alinity System Medical Dialogues Bureau26 Oct 2019 3:45 AM GMTNew Delhi: Abbott recently announced the Australian Red Cross Blood Service (Australian Blood Service) has signed a multiple-year agreement for Abbott'...
Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management Farhat Nasim16 Oct 2019 4:10 AM GMTNew Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine ...
Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain Medical Dialogues Bureau29 Sep 2019 4:25 AM GMTProclaim XR is currently under review for CE Mark. It is the latest advancement from Abbott, featuring upgradeable software and consumer-friendly techn...
